Moneycontrol
Get App
Last Updated : Oct 30, 2015 10:21 AM IST | Source: CNBC-TV18

Stocks in news: ICICI, Dr Reddy's, HCL Tech, Cipla, Nestle

ICICI Bank | ITC | Dr Reddy's Labs | Glenmark Pharma | Sonata Software | Polaris | HCL Technologies | SpiceJet | Blue Star | Cipla | Emami | Torrent Pharma | Jubilant Life | Grasim | Ador Welding | Crompton Greaves | Bharat Electronics | HCC | Nestle India | State Bank Of Travancore and IOC are stocks, which are in the news today.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Here are stocks that are in news today:


Results Today: ICICI Bank, ITC, Kotak Mahindra Bank, Larsen & Toubro, Titan Company, Suzlon Energy, Apollo Tyres, Century Textiles, Ajanta Pharma, IPCA Lab, Mahindra Lifespace, Karnataka Bank, Merck, Shoppers Stop, Religare Enterprises, Kalyani Steels, Jagran Prakashan, Gujarat Alkalies & Chemicals, Atul, 3M India, Century Enka, Elgi Equipments, EPC Industries, Gemini Communications, Jindal Drilling, Maharashtra Seamless, Munjal Showa, Nocil, Orient Paper, Sanghvi Forging, Smartlink Network, Subros, Srikalahasthi Pipes, TTML, Uttam Galva Steels, V-Mart Retail


Dr Reddy's Labs Q2
-Consolidated net profit at Rs 722 crore versus Rs 574.1 crore (YoY)
-Consolidated total income at Rs 3,989 crore versus Rs 3,587.8 crore (YoY)
-Consolidated operating profit at Rs 925.8 crore versus Rs 646.5 crore (YoY)
-Reported EBITDA margin at 28.6 percent versus 24.3 percent (YoY)
-North America revenue up 32 percent at Rs 1,860 crore (YoY)
-Global generics segment revenue up 15 percent at Rs 3,280 crore (YoY)
-Emerging markets revenue down 22 percent at Rs 660 crore (YoY)
-Russia revenue down 29 percent at Rs 290 crore (YoY)
-Rest Of World revenue down 24 percent at Rs 270 crore (YoY)
-India revenue up 14 percent at Rs 550 crore (YoY)
-Europe revenue up 65 percent at Rs 210 crore (YoY)
-Pharma services & active ingredients revenue down 7 percent at Rs 590 crore (YoY)
-Forex loss of Rs 35 crore versus forex gain of Rs 24.3 crore (YoY)
-Total number of DMF filings as on September 30 at 755

Close

Cigniti Technologies Q2
-Consolidated net profit up 18.7 percent at Rs 12.7 crore versus Rs 10.7 crore (QoQ)
-Consolidated total income up 12.1 percent at Rs 146.1 crore versus Rs 130.3 crore (QoQ)


State Bank Of Travancore Q2
-Net profit at Rs 102.8 crore versus Rs 19.2 crore (YoY)
-Gross NPAs at 3.82 percent versus 4.03 percent (QoQ)
-Net NPAs at 2.27 percent versus 2.47 percent (QoQ)
-Provisions at Rs 231.3 crore versus Rs 301.6 crore (QoQ); versus Rs 241.5 crore (YoY)
-Tax expense at Rs 39 crore versus Rs 13.9 crore (YoY)
-NII at Rs 645 crore versus Rs 582 crore (YoY)
-Gross NPAs at Rs 2,569.1 crore Rs 2,759.2 crore (QoQ)
-Net NPAs at Rs 1,498 crore versus Rs 1,653.9 crore (QoQ)


MRPL Q2
-Net loss at Rs 909.5 crore versus loss of Rs 951.5 crore (YoY)
-Total income down 35.8 percent at Rs 10,221 crore versus Rs 15,912 crore (YoY)


HCC Q2
-Net profit at Rs 38.4 crore versus Rs 6.8 crore (YoY)
-Total income at Rs 961.8 crore versus Rs 959 crore (YoY)
-HCC says current order book at Rs 16,988 crore excluding L1 contracts worth Rs 4,381 crore


Nestle India Q3
-Net profit at Rs 124.2 crore versus Rs 311.3 crore (YoY)
-Total income at Rs 1,742.4 crore versus Rs 2,570.4 crore (YoY)
-EBITDA at Rs 288 crore versus Rs 548 crore (YoY)
-EBITDA margin at 16.5 percent versus 21.3 percent (YoY)
-Exceptional item at Rs 24.5 crore


Nestle India says
-Q3 results impacted by Maggi noodles issue
-MD Suresh Narayanan has been given additional responsibility as chairman
-Have commenced manufacturing of Maggi noodles at 3 plants
-After clearance from labs, keen to re-introduce Maggi at the earliest
-Export sales decreased by 6.4 percent due to Maggi noodles issue
-Saw lower sales in Nepal due to blockage of border in September-end
-In talks to restart Maggi noodles production at Himachal & Uttarakhand units
-Sales of Rs 15.3 crore reversed in Q3 due to Maggi noodles stock being withdrawn


GIC Housing Q2
-Net profit at Rs 29.8 crore versus Rs 25.8 crore (YoY)
-Total income at Rs 215.6 crore versus Rs 178.7 crore (YoY)


Bharat Electronics (BEL) Q2
-Net profit at Rs 206.7 crore versus Rs 147 crore (YoY)
-Total income at Rs 1,467.7 crore versus Rs 1,294 crore (YoY)


Crompton Greaves Q2
-Consolidated net profit at Rs 52.1 crore versus Rs 69.6 crore (YoY)
-Consolidated total income at Rs 3,216.1 crore versus Rs 3,430.3 crore (YoY)


Essel Propack Q2
-Consolidated net profit at Rs 59.3 crore versus Rs 38.5 crore (YoY)
-Consolidated total income at Rs 535.3 crore versus Rs 595.1 crore (YoY)


Ador Welding Q2
-Net profit at Rs 3.4 crore versus Rs 20.3 crore (YoY)
-Total income at Rs 91.8 crore versus Rs 87.7 crore (YoY)
-Ador Welding appoints Girish Anant Patkar as CFO


RPG Life Q2
-Net profit at Rs 2.6 crore versus loss of Rs 7.4 crore (YoY)
-Total income at Rs 68.4 crore versus Rs 57.6 crore (YoY)


Grasim Q2
-Net profit up 13 percent at Rs 338.2 crore (YoY)
-Total income up 14.9 percent at Rs 1,838 crore (YoY)
-Operating profit up 32.6 percent at Rs 283.8 crore (YoY)
-Operating margin at 15.4 percent versus 13.4 percent (YoY)
-Effective tax rate at 13.9 percent versus 15.4 percent (YoY)
-VSF business revenue up 13 percent at Rs 1,436.8 crore (YoY)
-Chemicals business revenue up 26 percent at Rs 523 crore (YoY)


HeidelbergCement Q2
-Net profit at Rs 3.4 crore versus Rs 2.5 crore (YoY)
-Total income at Rs 402.7 crore versus Rs 406.1 crore (YoY)


Alstom T&D India Q2
-Net profit at Rs 46.3 crore versus Rs 35.6 crore (YoY)
-Total income at Rs 905.3 crore versus Rs 913.7 crore (YoY)


Jubilant Life Q2
-Consolidated net profit at Rs 115.8 crore versus loss of Rs 94.1 crore (YoY)
-Consolidated total income at Rs 1,463 crore versus Rs 1,371.1 crore (YoY)


Torrent Pharma Q2
-Consolidated net profit at Rs 568 crore versus Rs 198 crore (YoY)
-Consolidated total income at Rs 1,691 crore versus Rs 1,217 crore (YoY)


Emami Q2
-Consolidated net profit at Rs 61.3 crore versus Rs 91.5 crore (YoY)
-Consolidated total income at Rs 574.6 crore versus Rs 489.6 crore (YoY)
-Consolidated EBITDA at Rs 152 crore versus Rs 113 crore (YoY)
-Consolidated EBITDA margin at 26.5 percent versus 23.1 percent (YoY)


Praj Industries Q2
-Consolidated net profit at Rs 4.7 crore versus Rs 25 crore (YoY)
-Consolidated total income at Rs 203 crore versus Rs 265 crore (YoY)


Glenmark Pharma Q2
-Consolidated net profit at Rs 198 crore versus Rs 165 crore (YoY)
-Consolidated revenue at Rs 1,909 crore versus Rs 1,680.7 crore (YoY)
-Consolidated EBITDA at Rs 402 crore versus Rs 335.2 crore (YoY)
-Consolidated EBITDA margin at 21 percent versus 20 percent (YoY)
-India business up 27.3 percent at Rs 608.5 crore (YoY)
-US business up 17.9 percent at Rs 598.4 crore (YoY)
-Europe business up 22.8 percent at Rs 160.3 crore (YoY)
-Rest Of World business up 21.2 percent at Rs 211 crore (YoY)
Glenmark Pharma says
-Sanofi not to pursue development of Vatelizumab molecule further
-Company will continue to pursue relicensing of GBR 500 after its return from Sanofi


SKF India Q3
-Net profit down 14.7 percent at Rs 50 crore versus Rs 58.6 crore (YoY)
-Total income down 2.3 percent at Rs 598.7 crore versus Rs 612.8 crore (YoY)


IOC
-IOC to hike fuel supplies to Nepal: BS
-IOC, Delonex win oil block in Mozabique: PTI


Blue Star
-Enters into JV in MEP contracting business with WJ Towell, Oman
-Acquires 51 percent stake in JV entity, Blue Star Oman Electro-Mechanical Company LLC


SpiceJet says Sanjiv Kapoor resigns as COO w.e.f October 31
Sources say
-SpiceJet COO Sanjiv Kapoor likely to join Vistara Airlines
-Sanjiv Kapoor likely to join Vistara as chief commercial officer
-Sanjiv Kapoor may look at Vistara's network planning, revenue & sales management
-Vistara's present CCO Giam Ming Toh likely to step down
-Formal announcement on Sanjiv Kapoor joining Vistara may be made today

Other stocks and sectors that are in news today:
-Sonata Software to acquire IBIS for USD 14 million: BS
-Polaris gets board approval to hive off company's BPO business
-HCL Tech acquires CRM services provider PowerObjects
-Cipla to sell its entire 25 percent stake in Biomab Holding, Hong Kong for USD 25 million
-Glenmark Pharma gets tentative US FDA nod for epilepsy drug Lacosamide

First Published on Oct 30, 2015 08:20 am
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant